Loading data
UGNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 5.4 m USD | 5.72 m USD | 5.48 m USD | 6 m USD | 5.75 m USD |
| Research and development expense | 463.64 k USD | 456.78 k USD | 463.99 k USD | 490.77 k USD | 478.64 k USD |
| Operating profit | 2.24 m USD | 3.65 m USD | 2.86 m USD | 4.04 m USD | 5.67 m USD |
| Profit before tax | 2.64 m USD | 4.11 m USD | 3.25 m USD | 3.23 m USD | 5.88 m USD |
| Income tax expense | 537.28 k USD | 857.58 k USD | 669.41 k USD | 658.17 k USD | 1.22 m USD |
| Net income (reported basis) | 2.11 m USD | 3.25 m USD | 2.58 m USD | 2.57 m USD | 4.66 m USD |
| Basic earnings per share | 0.46 USD/share | 0.71 USD/share | 0.56 USD/share | 0.56 USD/share | 1.01 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.